Pain management at the end of life: A comparative study of cancer, dementia, and chronic obstructive pulmonary disease patients

Palliative Medicine

Volumn 29, Issue 5, 2015, Pages 464-469

  Romem, Ayal ^f   Romem, Anat ^a   Tom, Sarah E ^b   Beauchene, Michelle ^c   Babington, Lynn ^d   Scharf, Steven M ^e  

^a ACADEMIC COLLEGE OF TEL AVIV YAFFO   (Israel)

^b UNIVERSITY OF MARYLAND   (United States)

^c NORTHEASTERN UNIVERSITY   (United States)

^d FAIRFIELD UNIVERSITY SCHOOL OF NURSING   (United States)

^e UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^f SHAARE ZEDEK MEDICAL CENTER   (Israel)

Author keywords

cancer; chronic obstructive pulmonary disease dementia; opiates; Pain management; palliative care

Indexed keywords

OPIATE; NARCOTIC ANALGESIC AGENT;

AGED; ANALGESIA; ARTICLE; CANCER PATIENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; COMPARATIVE STUDY; DEMENTIA; FEMALE; HEALTH CARE UTILIZATION; HOSPICE CARE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEOPLASM; PAIN; PAIN ASSESSMENT; PAIN PARAMETERS; PREVALENCE; TERMINAL CARE; VERY ELDERLY; COMPLICATION; MIDDLE AGED; PALLIATIVE THERAPY; PROCEDURES; RETROSPECTIVE STUDY; STANDARDS;

AGED; AGED, 80 AND OVER; ANALGESICS, OPIOID; DEMENTIA; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PAIN; PAIN MANAGEMENT; PALLIATIVE CARE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES; TERMINAL CARE;

EID: 84929147336     PISSN: 02692163     EISSN: 1477030X     Source Type: Journal    
DOI: 10.1177/0269216315570411     Document Type: Article

References (39)

1. Strassels SA, Blough DK, Hazlet TK, et al. Pain, demographics, and clinical characteristics in persons who receive hospice care in the United States. J Pain Symptom Manage. 2006; 32: 519-531
2. Steinhauser KE, Arnold RM, Olsen MK, et al. Comparing three life-limiting diseases: does diagnosis matter or is sick, sick?. J Pain Symptom Manage. 2011; 42: 331-341
3. McMillan SC, Tittle M. A descriptive study of the management of pain and pain-related side effects in a cancer center and a hospice. Hosp J. 1995; 10: 89-107
4. Kutner JS, Kassner CT, Nowels DE. Symptom burden at the end of life: hospice providers' perceptions. J Pain Symptom Manage. 2001; 21: 473-480
5. Claessens MT, Lynn J, Zhong Z, et al. Dying with lung cancer or chronic obstructive pulmonary disease: insights from SUPPORT. J Am Geriatr Soc. 2000; 48: S146-S153
6. Brooksbank M. Palliative care: where have we come from and where are we going?. Pain. 2009; 144: 233-235
7. National Vital Statistics Reports. Deaths, preliminary data for 2011, http://www.cdc.gov/nchs/data/nvsr/nvsr61/nvsr61-06.pdf (2014, accessed 1 February 2014).
8. 2012 Alzheimer's disease facts and figure, http://www.alz.org/downloads/facts-figures-2012.pdf (2012, accessed 1 February 2014).
9. Connor SR, Tecca M, Lund Person J, et al. Measuring hospice care: the National Hospice and Palliative Care Organization National Hospice Data Set. J Pain Symptom Manage. 2004; 28: 316-328
10. Hendriks SA, Smalbrugge M, Hertog CM, et al. Dying with dementia: symptoms, treatment, and quality of life in the last week of life. J Pain Symptom Manage. 2014; 47: 710-720
11. Van der Steen JT. Dying with dementia: what we know after more than a decade of research. J Alzheimers Dis. 2010; 22: 37-55
12. HajGhanbari B, Holsti L, Road JD, et al. Pain in people with chronic obstructive pulmonary disease (COPD). Respir Med. 2012; 106: 998-1005
13. Solano JP, Gomes B, Higginson IJ. A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease. J Pain Symptom Manage. 2006; 31: 58-69
14. ICD-9-CM International Classification of Diseases, 9th Revision, Clinical Modification. 9-CM International Classification of Diseases, 9th Revision, Clinical Modification. 5th ed.Los Angeles, CA: Practice Management Information Corporation, 1997. Los Angeles, CA: Practice Management Information Corporation; 1997:
15. Mor V, Laliberte L, Morris JN, et al. The Karnofsky performance status scale. An examination of its reliability and validity in a research setting. Cancer. 1984; 53: 2002-2007
16. Pereira J, Lawlor P, Vigano A, et al. Equianalgesic dose ratios for opioids. A critical review and proposals for long-term dosing. J Pain Symptom Manage. 2001; 22 (2). 672-687
17. De Conno F, Caraceni A, Gamba A, et al. Pain measurement in cancer patients: a comparison of six methods. Pain. 1994; 57: 161-166
18. Farrar JT, Portenoy RK, Berlin JA, et al. Defining the clinically important difference in pain outcome measures. Pain. 2000; 88: 287-294
19. Farrar JT. What is clinically meaningful: outcome measures in pain clinical trials. Clin J Pain. 2000; 16: S106-S112
20. Warden V, Hurley AC, Volicer L. Development and psychometric evaluation of the PAINAD (Pain Assessment in Advanced Dementia). J Am Med Dir Assoc. 2003; 20 (1). 31-43
21. Smith M. Pain assessment in nonverbal older adults with advanced dementia. Perspect Psychiatr Care. 2005; 41 (3). 99-113
22. Russell PB, Aveyard SC, Oxenham DR. An assessment of methods used to evaluate the adequacy of cancer pain management. J Pain Symptom Manage. 2006; 32: 581-588
23. Strassel SA, Bluogh DK, Veenstra DL, et al. Clinical and demographic characteristics help explain variations in pain at the end of life. J Pain Symptom Manage. 2008; 35: 10-19
24. Shega JW, Hougham GW, Stocking CB, et al. Patients dying with dementia: experience at the end of life and impact of hospice care. J Pain Symptom Manage. 2008; 35: 499-507
25. SUPPORT principal investigators: a controlled trial to improve care for seriously ill hospitalized patients. JAMA. 1995; 274: 1591-1598
26. Steindal SA, Bredal IS, Wergeland LS, et al. Pain control at the end of life: a comparative study of hospitalized cancer and noncancer patients. Scand J Caring Sci. 2011; 25: 771-779
27. Klinkenberg M, Willems DL, van der Wal G, et al. Symptom burden in the last week of life. J Pain Symptom Manage. 2004; 27: 5-13
28. Kutner JS, Bryant LL, Beaty BL, et al. Time course and characteristics of symptom distress and quality at the end of life. J Pain Symptom Manage. 2007; 34: 227-236
29. Brorson H, Plymoth H, Örmon K, et al. Pain relief at the end of life: nurses' experiences regarding end-of-life pain relief in patients with dementia. Pain Manag Nurs. 2014; 15 (1). 315-323
30. Wilkie DJ, Ezenwa MO. Pain and symptom management in palliative care and at end of life. Nurs Outlook. 2012; 60: 357-364
31. Bentsen SB, Rustøen T, Miaskowski C. Differences in subjective and objective respiratory parameters in patients with chronic obstructive pulmonary disease with and without pain. Int J Chron Obstruct Pulmon Dis. 2012; 7: 137-143
32. Spathis A, Booth S. End of life care in chronic obstructive pulmonary disease: in search of a good death. Int J Chron Obstruct Pulmon Dis. 2008; 3: 11-29
33. Gordon DB, Dahl JL, Miaskowski C, et al. American Pain Society recommendations for improving the quality of acute and cancer pain management. Arch Intern Med. 2005; 165: 1574-1580
34. Gordon DB, Rees SM, McCausland MP, et al. Improving reassessment and documentation of pain management. Jt Comm J Qual Patient Saf. 2008; 34: 509-517
35. Ellershaw J, Smith C, Overril S, et al. Care of the dying: setting standards for symptom control in the last 48 hours of life. J Pain Symptom Manage. 2001; 21: 12-17
36. Rocker G, Horton R, Currow D, et al. Palliation of dyspnea in advanced COPD: revisiting a role for opioids. Thorax. 2009; 64: 910-915
37. Mahler DA, Selecky PA, Harrod CG, et al. American College of Chest Physicians consensus statement on the management of dyspnea in patient with advanced lung or heart disease. Chest. 2010; 137 (3). 674-691
38. Stirling CL, Kurowska A, Tookman A. The use of phenobarbitone in the management of agitation and seizures at the end of life. J Pain Symptom Manage. 1999; 17: 363-368
39. Prommer E. Role of haloperidol in palliative medicine: an update. Am J Hosp Palliat Care. 2012; 29: 295-301